Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 8.39B | 6.61B | 5.75B | 4.76B | 3.58B |
Gross Profit | 3.06B | 1.88B | 2.28B | 1.63B | 1.08B |
EBITDA | -1.67B | 558.00M | 1.03B | 890.92M | 653.30M |
Net Income | -2.70B | -422.30M | 557.39M | 495.74M | 310.46M |
Balance Sheet | |||||
Total Assets | 18.21B | 19.25B | 10.79B | 8.71B | 6.57B |
Cash, Cash Equivalents and Short-Term Investments | 2.25B | 1.63B | 1.44B | 2.15B | 1.18B |
Total Debt | 10.37B | 9.21B | 3.68B | 2.62B | 3.77B |
Total Liabilities | 12.79B | 11.64B | 5.56B | 4.12B | 5.05B |
Stockholders Equity | 5.41B | 7.61B | 5.23B | 4.59B | 1.51B |
Cash Flow | |||||
Free Cash Flow | -775.41M | -2.72B | -1.62B | -382.82M | 281.26M |
Operating Cash Flow | 885.16M | -953.77M | -119.25M | 443.38M | 568.30M |
Investing Cash Flow | -1.54B | -6.14B | -1.73B | -849.16M | -300.64M |
Financing Cash Flow | 1.28B | 7.30B | 1.12B | 1.38B | 241.38M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | ¥23.60B | 11.71 | 2.82% | 10.29% | 50.74% | ||
79 Outperform | ¥14.16B | 9.07 | 3.33% | 3.96% | 482.92% | ||
76 Outperform | ¥17.27B | 7.71 | 2.18% | 2.21% | -5.13% | ||
74 Outperform | ¥11.35B | 6.73 | 1.59% | 20.12% | 17.45% | ||
62 Neutral | $34.81B | 6.83 | -11.82% | 2.06% | 6.36% | -8.52% | |
46 Neutral | ¥21.05B | ― | ― | 32.53% | -248.26% | ||
45 Neutral | ¥13.25B | 9.97 | ― | ― | ― |
OXIDE Corporation addressed key financial and strategic questions during its recent results meeting, highlighting a reclassification of R&D expenses that will not affect overall financial plans. Despite challenges in the SiC industry, including a slowdown in the EV market and the bankruptcy of a partner company, OXIDE maintains a strong position with a robust domestic supply chain strategy and continues to focus on ultra-high voltage applications. In the healthcare sector, the company has begun shipments to a major PET manufacturer, with plans for increased volumes, positioning this as a growth driver for the fiscal year.
OXIDE Corporation has announced the issuance of new shares as part of a restricted stock compensation plan for its employees, aimed at enhancing corporate value and aligning employee interests with shareholder value. This initiative reflects the company’s strategic focus on long-term growth and employee engagement, potentially impacting its market position and stakeholder relations positively.
OXIDE Corporation reported a non-operating expense of JPY 149 million due to foreign exchange losses in the first quarter of the fiscal year ending February 2026. This loss resulted from the revaluation of intra-group loans to an overseas subsidiary. Despite this setback, the company has not revised its annual forecast, attributing the decision to the fluctuating nature of exchange rates, and will update stakeholders if necessary.
OXIDE Corporation reported its consolidated financial results for the three months ended May 31, 2025, showing a significant increase in net sales by 28.8% year-on-year, reaching 1,787 million yen. However, the company faced operating and ordinary losses, with a profit attributable to owners of the parent at a negative 274 million yen. Despite these losses, the company forecasts a positive turnaround for the full fiscal year ending February 28, 2026, with expected net sales of 8,713 million yen and a profit attributable to owners of the parent of 74 million yen. This indicates a potential recovery and growth trajectory for OXIDE Corporation, which could impact its market positioning and stakeholder confidence.
OXIDE Corporation’s recent announcement outlines their business plan and growth potential for the fiscal year 2025, emphasizing innovation in their key sectors. The release highlights the company’s strategic focus areas and potential impacts on its operations and market positioning, aiming to enhance stakeholder value.
OXIDE Corporation announced the results of its post-vesting stock compensation plan for employees, determining that 50% of the granted units have vested. This decision impacts 95 employees and involves 3,850 shares, with a portion paid in cash. The move reflects the company’s commitment to rewarding its workforce and aligning employee incentives with corporate performance, potentially enhancing employee satisfaction and retention.